June 15, 2021: The interim recommendations for use of Pfizer-BioNTech BNT162b2, Moderna mRNA–1273 and Janssen Ad26.COV2.S vaccines have been updated to reflect latest evidence.
For further information, see below:Interim recommendations for use of the Pfizer–BioNTech COVID-19 vaccine, BNT162b2, under Emergency Use Listing
- Advertisement -
Interim recommendations for the use of the Janssen Ad26.COV2.S (COVID-19) vaccine
Interim recommendations for the use of the Janssen Ad26.COV2.S (COVID-19) vaccine
